bullish
Lunit IPO Preview: A Pioneer in AI-Based Cancer Diagnosis and Treatment Solutions
448 Views20 Jun 2022 19:42
Lunit is getting ready to complete its IPO in Korea in July. Lunit is one of the leading companies in Korea that specializes in AI-based cancer diagnosis and treatment solutions.
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 9-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- KOSDAQ150 Rebalance in December 2023 Highlighted by Locals14 Nov 2023
- Lunit (Specializes in AI-Based Cancer Diagnosis and Treatment): Rights Offering of 202 Billion Won26 Aug 2023
- End of Mandatory Lock-Up Periods for 41 Companies in Korea in July 202330 Jun 2023
- Lunit IPO Preview: A Pioneer in AI-Based Cancer Diagnosis and Treatment Solutions20 Jun 2022
x